BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21545756)

  • 1. Smith-Magenis syndrome: haploinsufficiency of RAI1 results in altered gene regulation in neurological and metabolic pathways.
    Elsea SH; Williams SR
    Expert Rev Mol Med; 2011 Apr; 13():e14. PubMed ID: 21545756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smith-Magenis syndrome results in disruption of CLOCK gene transcription and reveals an integral role for RAI1 in the maintenance of circadian rhythmicity.
    Williams SR; Zies D; Mullegama SV; Grotewiel MS; Elsea SH
    Am J Hum Genet; 2012 Jun; 90(6):941-9. PubMed ID: 22578325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of the Retinoic Acid Induced 1 gene (RAI1) in patients with suspected Smith-Magenis syndrome without the 17p11.2 deletion.
    Vilboux T; Ciccone C; Blancato JK; Cox GF; Deshpande C; Introne WJ; Gahl WA; Smith AC; Huizing M
    PLoS One; 2011; 6(8):e22861. PubMed ID: 21857958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smith-Magenis Syndrome-Clinical Review, Biological Background and Related Disorders.
    Rinaldi B; Villa R; Sironi A; Garavelli L; Finelli P; Bedeschi MF
    Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rai1 haploinsufficiency causes reduced Bdnf expression resulting in hyperphagia, obesity and altered fat distribution in mice and humans with no evidence of metabolic syndrome.
    Burns B; Schmidt K; Williams SR; Kim S; Girirajan S; Elsea SH
    Hum Mol Genet; 2010 Oct; 19(20):4026-42. PubMed ID: 20663924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MBD5 haploinsufficiency is associated with sleep disturbance and disrupts circadian pathways common to Smith-Magenis and fragile X syndromes.
    Mullegama SV; Pugliesi L; Burns B; Shah Z; Tahir R; Gu Y; Nelson DL; Elsea SH
    Eur J Hum Genet; 2015 Jun; 23(6):781-9. PubMed ID: 25271084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smith Magenis syndrome: First case of congenital heart defect in a patient with Rai1 mutation.
    Onesimo R; Delogu AB; Blandino R; Leoni C; Rosati J; Zollino M; Zampino G
    Am J Med Genet A; 2022 Jul; 188(7):2184-2186. PubMed ID: 35373511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of classical 17p11.2 deletions, an atypical deletion and RAI1 alterations in patients with features suggestive of Smith-Magenis syndrome.
    Vieira GH; Rodriguez JD; Carmona-Mora P; Cao L; Gamba BF; Carvalho DR; de Rezende Duarte A; Santos SR; de Souza DH; DuPont BR; Walz K; Moretti-Ferreira D; Srivastava AK
    Eur J Hum Genet; 2012 Feb; 20(2):148-54. PubMed ID: 21897445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAI1 variations in Smith-Magenis syndrome patients without 17p11.2 deletions.
    Girirajan S; Elsas LJ; Devriendt K; Elsea SH
    J Med Genet; 2005 Nov; 42(11):820-8. PubMed ID: 15788730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smith-Magenis syndrome.
    Elsea SH; Girirajan S
    Eur J Hum Genet; 2008 Apr; 16(4):412-21. PubMed ID: 18231123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RAI1 transcription factor activity is impaired in mutants associated with Smith-Magenis Syndrome.
    Carmona-Mora P; Canales CP; Cao L; Perez IC; Srivastava AK; Young JI; Walz K
    PLoS One; 2012; 7(9):e45155. PubMed ID: 23028815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonrecurrent PMP22-RAI1 contiguous gene deletions arise from replication-based mechanisms and result in Smith-Magenis syndrome with evident peripheral neuropathy.
    Yuan B; Neira J; Gu S; Harel T; Liu P; Briceño I; Elsea SH; Gómez A; Potocki L; Lupski JR
    Hum Genet; 2016 Oct; 135(10):1161-74. PubMed ID: 27386852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A de novo mutation (p.S1419F) of Retinoic acid induced 1 is responsible for a patient with Smith-Magenis syndrome exhibiting schizophrenia.
    Yu R; Liu L; Chen C; Lin ZJ; Xu JM; Fan LL
    Gene; 2023 Jan; 851():147028. PubMed ID: 36334618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. rAAV-CRISPRa therapy corrects Rai1 haploinsufficiency and rescues selective disease features in Smith-Magenis syndrome mice.
    Chang HC; Lee YJ; Javed S; Haque M; Chang YT; Lin YC; Oram C; Huang WH
    J Biol Chem; 2023 Jan; 299(1):102728. PubMed ID: 36410433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoic acid-induced 1 gene haploinsufficiency alters lipid metabolism and causes autophagy defects in Smith-Magenis syndrome.
    Turco EM; Giovenale AMG; Sireno L; Mazzoni M; Cammareri A; Marchioretti C; Goracci L; Di Veroli A; Marchesan E; D'Andrea D; Falconieri A; Torres B; Bernardini L; Magnifico MC; Paone A; Rinaldo S; Della Monica M; D'Arrigo S; Postorivo D; Nardone AM; Zampino G; Onesimo R; Leoni C; Caicci F; Raimondo D; Binda E; Trobiani L; De Jaco A; Tata AM; Ferrari D; Cutruzzolà F; Mazzoccoli G; Ziviani E; Pennuto M; Vescovi AL; Rosati J
    Cell Death Dis; 2022 Nov; 13(11):981. PubMed ID: 36411275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frameshift mutation hotspot identified in Smith-Magenis syndrome: case report and review of literature.
    Truong HT; Dudding T; Blanchard CL; Elsea SH
    BMC Med Genet; 2010 Oct; 11():142. PubMed ID: 20932317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early adolescent Rai1 reactivation reverses transcriptional and social interaction deficits in a mouse model of Smith-Magenis syndrome.
    Huang WH; Wang DC; Allen WE; Klope M; Hu H; Shamloo M; Luo L
    Proc Natl Acad Sci U S A; 2018 Oct; 115(42):10744-10749. PubMed ID: 30275311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotype-phenotype correlation in Smith-Magenis syndrome: evidence that multiple genes in 17p11.2 contribute to the clinical spectrum.
    Girirajan S; Vlangos CN; Szomju BB; Edelman E; Trevors CD; Dupuis L; Nezarati M; Bunyan DJ; Elsea SH
    Genet Med; 2006 Jul; 8(7):417-27. PubMed ID: 16845274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed diagnosis in a house of correction: Smith-Magenis syndrome due to a de novo nonsense RAI1 variant.
    Yeetong P; Vilboux T; Ciccone C; Boulier K; Schnur RE; Gahl WA; Huizing M; Laje G; Smith AC
    Am J Med Genet A; 2016 Sep; 170(9):2383-8. PubMed ID: 27311559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smith-Magenis syndrome protein RAI1 regulates body weight homeostasis through hypothalamic BDNF-producing neurons and neurotrophin downstream signalling.
    Javed S; Chang YT; Cho Y; Lee YJ; Chang HC; Haque M; Lin YC; Huang WH
    Elife; 2023 Nov; 12():. PubMed ID: 37956053
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.